Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 141

1.

Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.

Prague JK, Roberts RE, Comninos AN, Clarke S, Jayasena CN, Nash Z, Doyle C, Papadopoulou DA, Bloom SR, Mohideen P, Panay N, Hunter MS, Veldhuis JD, Webber LC, Huson L, Dhillo WS.

Lancet. 2017 May 6;389(10081):1809-1820. doi: 10.1016/S0140-6736(17)30823-1. Epub 2017 Apr 3.

2.

Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.

Achilli C, Pundir J, Ramanathan P, Sabatini L, Hamoda H, Panay N.

Fertil Steril. 2017 Feb;107(2):475-482.e15. doi: 10.1016/j.fertnstert.2016.10.028. Epub 2016 Dec 1. Review.

PMID:
27916205
3.

Climacteric: past, present and future!

Panay N, Fenton A.

Climacteric. 2016 Oct;19(5):413-4. doi: 10.1080/13697137.2016.1227543. No abstract available.

PMID:
27631561
4.

The REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey in Europe: Country-specific comparisons of postmenopausal women's perceptions, experiences and needs.

Nappi RE, Palacios S, Particco M, Panay N.

Maturitas. 2016 Sep;91:81-90. doi: 10.1016/j.maturitas.2016.06.010. Epub 2016 Jun 15.

PMID:
27451325
5.

Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder.

Ismaili E, Walsh S, O'Brien PMS, Bäckström T, Brown C, Dennerstein L, Eriksson E, Freeman EW, Ismail KMK, Panay N, Pearlstein T, Rapkin A, Steiner M, Studd J, Sundström-Paromma I, Endicott J, Epperson CN, Halbreich U, Reid R, Rubinow D, Schmidt P, Yonkers K; Consensus Group of the International Society for Premenstrual Disorders.

Arch Womens Ment Health. 2016 Dec;19(6):953-958. doi: 10.1007/s00737-016-0631-7. Epub 2016 Jul 5.

PMID:
27378473
6.

Global consensus statement on menopausal hormone therapy - an update.

Fenton A, Panay N.

Climacteric. 2016 Aug;19(4):311-2. doi: 10.1080/13697137.2016.1202475. No abstract available.

PMID:
27376626
7.

Cardiovascular risk assessment in women - an update.

Collins P, Webb CM, de Villiers TJ, Stevenson JC, Panay N, Baber RJ.

Climacteric. 2016 Aug;19(4):329-36. doi: 10.1080/13697137.2016.1198574. Epub 2016 Jun 21. Review.

PMID:
27327421
8.

Menopause in the 21st century: the need for research and development.

Panay N, Fenton A.

Climacteric. 2016 Jun;19(3):213-4. doi: 10.1080/13697137.2016.1179430. No abstract available.

PMID:
27148764
9.

Estrogen, menopause and joints.

Fenton A, Panay N.

Climacteric. 2016 Apr;19(2):107-8. doi: 10.3109/13697137.2016.1151151. No abstract available.

PMID:
26911312
10.

2016 IMS Recommendations on women's midlife health and menopause hormone therapy.

Baber RJ, Panay N, Fenton A; IMS Writing Group.

Climacteric. 2016 Apr;19(2):109-50. doi: 10.3109/13697137.2015.1129166. Epub 2016 Feb 12.

PMID:
26872610
11.

Iatrogenic menopause following gynecological malignancy: time for action!

Panay N, Fenton A.

Climacteric. 2016;19(1):1-2. doi: 10.3109/13697137.2015.1127640. No abstract available.

PMID:
26732681
12.

Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?

Edwards D, Panay N.

Climacteric. 2016 Apr;19(2):151-61. doi: 10.3109/13697137.2015.1124259. Epub 2015 Dec 26. Review.

13.

Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey.

Nappi RE, Palacios S, Panay N, Particco M, Krychman ML.

Climacteric. 2016 Apr;19(2):188-97. doi: 10.3109/13697137.2015.1107039. Epub 2015 Nov 19. Erratum in: Climacteric. 2016 Apr;19(2):i.

14.

75 years on: a tribute to the contribution of Fuller Albright.

Fenton A, Panay N.

Climacteric. 2015;18 Suppl 2:1. doi: 10.3109/13697137.2015.1097026. Epub 2015 Nov 12. No abstract available.

PMID:
26565117
15.

What influences the age of menopause?

Fenton A, Panay N.

Climacteric. 2015;18(6):767-8. doi: 10.3109/13697137.2015.1097049. Epub 2015 Nov 12. No abstract available.

PMID:
26563605
16.

Diagnosis and management of menopause: summary of NICE guidance.

Sarri G, Davies M, Lumsden MA; Guideline Development Group.

BMJ. 2015 Nov 12;351:h5746. doi: 10.1136/bmj.h5746. No abstract available.

PMID:
26563259
17.

New guidelines--new hope?

Panay N, Fenton A.

Climacteric. 2015 Oct;18(5):661-2. doi: 10.3109/13697137.2015.1082293. No abstract available.

PMID:
26369584
18.

Genitourinary syndrome of the menopause--dawn of a new era?

Panay N.

Climacteric. 2015;18 Suppl 1:13-7. doi: 10.3109/13697137.2015.1070564. Review.

PMID:
26366795
19.

Hormone therapy and cardiovascular disease – are we back to the beginning?

Fenton A, Panay N.

Climacteric. 2015;18(4):437-8. doi: 10.3109/13697137.2015.1057958. No abstract available.

PMID:
26100243
20.

Severe PMS/PMDD - is it time for a new approach?

Panay N, Fenton A.

Climacteric. 2015 Jun;18(3):331-2. doi: 10.3109/13697137.2015.1041232. No abstract available.

PMID:
25966857

Supplemental Content

Loading ...
Support Center